What are Crinetics Pharmaceuticals's profit margins?

Crinetics Pharmaceuticals (CRNX) runs a 150.0% gross margin and a -3020.3% operating margin, with a -2747.2% net margin.

Where do Crinetics Pharmaceuticals's ratios come from?

Every ratio is computed from Crinetics Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Crinetics Pharmaceuticals CRNX Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Profitability
Operating margin	-3,020.3%+3,694pp	-6,714.8%+24,415pp	-31,130.2%-738pp	-30,392.2%+19,178pp	-49,569.7%-16,956pp
Net margin	-2,747.2%+3,299pp	-6,046.2%+21,517pp	-27,563.3%-995pp	-26,568.5%+16,623pp	-43,191.1%-14,470pp
Returns
Return on equity	-39.2%+1.0pp	-40.2%+4.2pp	-44.4%-7.5pp	-36.9%-6.1pp	-30.8%+1.2pp
Return on invested capital	-45.1%+5.4pp	-50.4%+10.2pp	-60.6%-12.3pp	-48.4%-5.1pp	-43.3%-2.1pp
Efficiency
Asset turnover	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Liquidity
Current ratio	18.6×+6.3×	12.3×-2.8×	15.1×-2.7×	17.8×-4.7×	22.5×-0.5×
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Per Share
Book value per share	$12.30+16.6%	$10.55-7.3%	$11.38-8.9%	$12.49-7.3%	$13.47-17.9%
Valuation
Market capitalization	$3.8B-13.9%	$4.42B+12.6%	$3.92B+35.3%	$2.9B-7.1%	$3.12B-34.2%
Price / sales	210.5×-363×	574×-1,981×	2,555.3×+473×	2,082.2×-2,024×	4,106.4×-457×
Price / book	3×-1.5×	4.5×+0.8×	3.7×+1.2×	2.5×0.0×	2.5×-1.1×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Crinetics Pharmaceuticals's profit margins?: Crinetics Pharmaceuticals (CRNX) runs a 150.0% gross margin and a -3020.3% operating margin, with a -2747.2% net margin.
Where do Crinetics Pharmaceuticals's ratios come from?: Every ratio is computed from Crinetics Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.